Giving hope to the elderly battling against the Coronavirus Pandemic, early test results for a coronavirus vaccine being developed by the University of Oxford show that it produces a robust immune response in elderly people.
AstraZeneca, which is developing the vaccine with Oxford University researchers is being perceived as a frontrunner in the race to produce a vaccine to protect against COVID-19.
The Financial Times report citing two unidentified people familiar with the finding said that the vaccine which the company is manufacturing has produced protective antibodies and T-cells in those belonging to the older age groups.
#CoronavirusPandemic #OxfordVaccine #AstraZeneca
